Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS. Shaded region = analyst consensus for the current and next fiscal year (27 analysts).
| Parameter | BaseValue |
|---|---|
Initial Cash Flow | |
| Growth Rate (Yr 1-5) | % |
| Growth Rate (Yr 6-10) | % |
| Terminal Growth Rate | % |
| Discount Rate | % |
Base Case $199.81 Implied EV: $66.25B |
What growth rate is the market pricing in at $407?
Market below historical growth — potential opportunity.
Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.
Insufficient data for Beneish M-Score calculation (requires 2+ years).
"Market is pessimistic — investigate whether fears are temporary or structural"
Significantly overvalued despite market fear — fear alone does not justify the premium
